King, M. T., Stockler, M. R., O’Connell, R. L., Buizen, L., Joly, F., Lanceley, A., . . . group, f. t. G. S. B. (2018). Measuring what matters MOST: Validation of the Measure of Ovarian Symptoms and Treatment, a patient-reported outcome measure of symptom burden and impact of chemotherapy in recurrent ovarian cancer. Quality of Life Research, 27(1), 59. https://doi.org/10.1007/s11136-017-1729-8
Chicago Style (17th ed.) CitationKing, Madeleine T., et al. "Measuring What Matters MOST: Validation of the Measure of Ovarian Symptoms and Treatment, a Patient-reported Outcome Measure of Symptom Burden and Impact of Chemotherapy in Recurrent Ovarian Cancer." Quality of Life Research 27, no. 1 (2018): 59. https://doi.org/10.1007/s11136-017-1729-8.
MLA (9th ed.) CitationKing, Madeleine T., et al. "Measuring What Matters MOST: Validation of the Measure of Ovarian Symptoms and Treatment, a Patient-reported Outcome Measure of Symptom Burden and Impact of Chemotherapy in Recurrent Ovarian Cancer." Quality of Life Research, vol. 27, no. 1, 2018, p. 59, https://doi.org/10.1007/s11136-017-1729-8.